Design and characterization of an aperture system and spot configuration for ocular treatments with a gantry‐based spot scanning proton beam

Abstract

AbstractBackground and purposeProton therapy is a key modality used in the treatment of ocular melanoma. Traditionally ocular sites are treated using a dedicated eyeline with a passively scattered proton beam and a brass aperture. This work aims to design and characterize a beam‐collimating aperture to treat ocular targets with a gantry‐based spot scanning proton beam.MethodsA plastic aperture system that slides into the gantry nozzle of a spot scanning proton beam was designed and constructed. It consists of an intermediate scraper layer to attenuate stray protons and a 3D‐printed patient‐specific aperture positioned 5.7 cm from the surface of the eye. The aperture system was modeled in TOPAS and Monte Carlo simulations were validated with film measurements. Two different spot configurations were investigated for treatment planning and characterized based on lateral penumbra, central axis (CAX) dose and relative efficiency. Alignment and leakage were investigated through experimental film measurements. Range was verified using a multi‐layer ionization chamber. Reference dose measurements were made with a PinPoint 3D ion chamber. Neutron dose was evaluated through Monte Carlo simulations.ResultsAperture alignment with radiation isocenter was determined to be within 0.31 mm at a gantry angle of 0°. A single‐spot configuration with a 10 mm diameter aperture yielded film‐measured lateral penumbras of 1 mm to 1.25 mm, depending on depth in the spread‐out Bragg peak. TOPAS simulations found that a single spot configuration results in a flat dose distribution for a 10 mm diameter aperture and provides a CAX dose of less than 106% for apertures less than 14 mm in diameter. For larger targets, adding four corner spots to fill in the dose distribution is beneficial. Trade‐offs between lateral penumbra, CAX dose and relative efficiency were characterized for different spot configurations and can be used for future clinical decision‐making. The aperture was experimentally determined to not affect proton beam range, and no concerning leakage radiation or neutron dose was identified. Reference dose measurements with a PinPoint ion chamber were within 2.1% of Monte Carlo calculated doses.ConclusionThe aperture system developed in this work provides a method of treating ocular sites on a gantry‐based spot scanning proton system. Additional work to develop compatible gaze tracking and gating infrastructure is ongoing.